Skip to main content
News

Stimulant Recalled


June 12, 2020

Citing the possibility bottles may contain tablets of mixed strengths, Teva Pharmaceuticals USA is voluntarily recalling 100-count bottles of dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate tablets (mixed amphetamine salts product). The recall was included in the June 10, 2020, US Food and Drug Administration (FDA) Enforcement Report. 

The following products, distributed throughout the United States and in Puerto Rico, were included in the recall:

Teva Pharmaceuticals initiated the recalls May 22, 2020. The FDA designated the recalls Class II on June 4, 2020, signaling use of the tablets could cause temporary or medically reversible adverse health consequences. A remote possibility of serious harm also exists. 

Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate tablets are available with a prescription for the treatment of attention-deficit/hyperactivity disorder and narcolepsy.

Jolynn Tumolo

Agree or disagree with an article? Share your professional thoughts on an article you read.

Your Name
10 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Back to Top